To Cite:
Wiwanitkit
V. Serological Screening Test as a Tool for Early Prevention of Cancerous Disorders,
Jundishapur J Microbiol.
2012
; 5(4):601-602.
doi: 10.5812/jjm.3722.
1.
Malfertheiner P, Selgrad M. Helicobacter pylori infection and current clinical areas of contention. Curr Opin Gastroenterol. 2010; 26(6): 618-23[DOI][PubMed]
2.
Zalabska E. [Does the authentication of the antibodies against Helicobacter pylori have contribution to its diagnosis?]. Klin Mikrobiol Infekc Lek. 2011; 17(1): 33-7[PubMed]
3.
Wiwanitkit V. Helicobacter pylori screening to prevent gastric cancer: an economical analysis for a tropical developing country. Asian Pac J Cancer Prev. 2010; 11(2): 571-2[PubMed]
4.
Xie F, Luo N, Lee HP. Cost effectiveness analysis of population-based serology screening and (13)C-Urea breath test for Helicobacter pylori to prevent gastric cancer: a markov model. World J Gastroenterol. 2008; 14(19): 3021-7[DOI][PubMed]
5.
Yoon SK. Recent advances in tumor markers of human hepatocellular carcinoma. Intervirology. 2008; 51: 34-41[DOI][PubMed]
6.
Lin SY, Chang ET, So SK. Why we should routinely screen Asian American adults for hepatitis B: a cross-sectional study of Asians in California. Hepatology. 2007; 46(4): 1034-40[DOI][PubMed]
7.
Wiwanitkit V. Cost concern on hepatitis B virus screening for workers pursuing work aboard. Travel Med Infect Dis. 2009; 7(5): 327[DOI][PubMed]
8.
Lim YA, Hyun BH, Kim DY. Effect of transfusion of fresh-frozen plasma on recipients' antibodies to hepatitis B surface antigen and hepatitis B surface antigen status in countries where hepatitis B virus is endemic. Vox Sang. 2002; 83(3): 209-13[DOI][PubMed]
9.
Louisirirotchanakul S,
Oota S,
Khuponsarb K,
Chalermchan W,
Phikulsod S,
Chongkolwatana V,
et al.
Occult hepatitis B virus infection in Thai blood donors. Transfusion. 2011; 51(7): 1532-40[DOI][PubMed]
10.
Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements. J Gastroenterol Hepatol. 2010; 25(4): 657-63[DOI][PubMed]
11.
Wiwanitkit V. Anti HCV seroprevalence among the voluntary blood donors in Thailand. Hematology. 2005; 10(5): 431-3[DOI][PubMed]
12.
Wiwanitkit V. Summary On The Prevalence Of Serum VCA-IgA Antibody Among Thai Patients With Lymphoma: An Implication For Risk And Screening Purpose. Int J Trop Med. 2005; 2(2)
13.
Cao SM,
Liu Z,
Jia WH,
Huang QH,
Liu Q,
Guo X,
et al.
Fluctuations of epstein-barr virus serological antibodies and risk for nasopharyngeal carcinoma: a prospective screening study with a 20-year follow-up. PLoS One. 2011; 6(4)[DOI][PubMed]
14.
Leung SF,
Tam JS,
Chan AT,
Zee B,
Chan LY,
Huang DP,
et al.
Improved accuracy of detection of nasopharyngeal carcinoma by combined application of circulating Epstein-Barr virus DNA and anti-Epstein-Barr viral capsid antigen IgA antibody. Clin Chem. 2004; 50(2): 339-45[DOI][PubMed]
15.
O TM, Yu G, Hu K, Li JC. Plasma Epstein-Barr virus immunoglobulin A and DNA for nasopharyngeal carcinoma screening in the United States. Otolaryngol Head Neck Surg. 2007; 136(6): 992-7[DOI][PubMed]
Readers' Comments